The article discusses components of a toolkit that physicians could use in everyday medicine, including rapid methods for identifying proteins in the blood and processing the resulting data. The potential of our proteomics toolkit hopefully brings us one step closer to a practical personalized medicine, the report states.
ARTICLE #4 FOR IMMEDIATE RELEASE Personalized medicine and ProteomicsLessons from Non-Small Cell Lung Cancer
DOWNLOAD PDF
http://pubs.acs.org/cgi-bin/sample.cgi/jprobs/asap/pdf/pr070046s.pdf
DOWNLOAD HTML
http://pubs.acs.org/cgi-bin/sample.cgi/jprobs/asap/html/pr070046s.html
CONTACT:
Fredrik Nyberg, Ph.D.
AstraZeneca R&D Molndal
Molndal, Sweden
Phone: 46-31-706-5203
Fax: 46-31-776-3828
Email: fredrik.nyberg@astrazeneca.com
ARTICLE #5 EMBARGOED FOR 9 A.M., EASTERN TIME, Aug. 6, 2007
Toward faster tests to identify carcinogens and other environmental toxins
Chemical & Engineering News
After years of frustration with traditional methods for testing the toxicity of chemicals in the environment, scientists are working to adapt faster, simpler screening methods that do not require animals, now used by the pharmaceutical industry to identify potential drug candidates, according to an article [insert link here] scheduled for the August 6 issue of Chemical & Engineering News (C&EN), ACSs weekly newsmagazine.
The article, written by C&EN Senior Editor Celia Henry Arnaud, explains that animal testing long has been the gold standard for environmental toxicology. But such tests take years to complete, cant always be confidently extrapolated to humans, and require the use of
'"/>
Contact: Michael Woods
m_woods@acs.org
202-872-4400
American Chemical Society
6-Aug-2007